Board-certified Ophthalmologist Dr. Emily Tomaselli joins Grand Rapids Ophthalmology
GRAND RAPIDS, Mich., Aug. 26, 2019 /PRNewswire-PRWeb/ -- Grand Rapids Ophthalmology (GRO) is pleased to announce the addition of Emily Tomaselli (formerly Rollenhagen) DO, to its growing team of eye care professionals. She is the most recent to join GRO's continued commitment and Purpose to Lead the Way, Improve Sight, and Change Lives.
Dr. Tomaselli is a board-certified ophthalmologist. She performs medical, diabetic, and routine eye exams, as well as cataract and laser surgeries. Dr. Tomaselli graduated from Michigan State University College of Osteopathic Medicine. She completed her ophthalmology residency from both Michigan State University Statewide Campus System St. John Providence Ascension Health System, and Albany Medical Center.
"We feel very fortunate to have Dr. Tomaselli join our team with her in-depth training and clinical experience," said Zach Smith, GRO's Executive Director. "She will be an asset in helping Grand Rapids Ophthalmology continue to provide the highest level of eye care to our patients." Dr. Tomaselli is board-certified by the American Board of Ophthalmology, the American Osteopathic Association, the American Society of Cataract and Refractive Surgery, as well as the Michigan Society of Eye Physicians and Surgeons.
PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia Corporation (TWSE: 6446), a global biopharmaceutical innovator based in Taiwan leveraging deep expertise and proven scientific principles to deliver new biologics in hematology and...
Concert Health, the leading Collaborative Care platform, and the Advancing Integrated Mental Health Solutions (AIMS) Center in the University of Washington Department of Psychiatry and Behavioral Sciences, today announced a three year, multi-state...
In this free webinar, learn the essential infrastructure requirements necessary for clinical sites to effectively manage cell therapy products in non-oncology clinical trials. Attendees will learn the key considerations in patient selection criteria...
After not getting a deal on Shark Tank in 2018, BoomBoom, the innovative brand that's been helping thousands of mouth breathers with its all-natural Nasal Sticks, reached $20M in sales. And today, it announces the launch of a $1 million WeFunder...
KanTime, the most comprehensive longitudinal EMR solution on the market, has earned HITRUST certified status for its post acute care solutions. HITRUST Risk-based, 2-year (r2) Certified status demonstrates that the organization has met demanding...
In this free webinar, learn how an mRNA immunization strategy opens a new avenue in the antibody production of difficult protein targets and accelerates the development of antibody drugs against difficult-to-express targets. Attendees will learn the...
